Mei Fen Shih

521 total citations
10 papers, 420 citations indexed

About

Mei Fen Shih is a scholar working on Molecular Biology, Biomaterials and Organic Chemistry. According to data from OpenAlex, Mei Fen Shih has authored 10 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Biomaterials and 2 papers in Organic Chemistry. Recurrent topics in Mei Fen Shih's work include Virus-based gene therapy research (2 papers), Skin Protection and Aging (2 papers) and RNA Interference and Gene Delivery (2 papers). Mei Fen Shih is often cited by papers focused on Virus-based gene therapy research (2 papers), Skin Protection and Aging (2 papers) and RNA Interference and Gene Delivery (2 papers). Mei Fen Shih collaborates with scholars based in Taiwan and Netherlands. Mei Fen Shih's co-authors include Jong Yuh Cherng, Wim E. Hennink, Ting Hou, H. Talsma, Li‐Yin Chen, Kuang‐Hung Pan, Chia‐Rui Shen and Chun‐Mei Hu and has published in prestigious journals such as Journal of Controlled Release, Molecules and International Journal of Pharmaceutics.

In The Last Decade

Mei Fen Shih

9 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mei Fen Shih Taiwan	9	123	118	111	79	75	10	420
Jong Yuh Cherng Taiwan	11	125 1.0×	141 1.2×	112 1.0×	81 1.0×	76 1.0×	12	483
Weiyan Quan China	9	269 2.2×	86 0.7×	39 0.4×	60 0.8×	97 1.3×	16	592
Dong‐Keon Kweon South Korea	12	239 1.9×	97 0.8×	37 0.3×	46 0.6×	85 1.1×	19	531
Dong Gyu Kim South Korea	11	109 0.9×	150 1.3×	24 0.2×	35 0.4×	159 2.1×	23	628
Cristina Blanco-Llamero Spain	10	132 1.1×	91 0.8×	25 0.2×	19 0.2×	98 1.3×	18	376
Л. С. Гальбрайх Russia	10	296 2.4×	69 0.6×	89 0.8×	116 1.5×	88 1.2×	118	541
Chaoxi Wu China	16	375 3.0×	113 1.0×	42 0.4×	49 0.6×	246 3.3×	31	711
Qinyuan Cheng China	3	196 1.6×	92 0.8×	23 0.2×	45 0.6×	83 1.1×	10	419
Le Hang Dang Vietnam	13	263 2.1×	93 0.8×	54 0.5×	58 0.7×	144 1.9×	36	587
Changyong Choi South Korea	12	350 2.8×	140 1.2×	68 0.6×	152 1.9×	141 1.9×	28	736

Countries citing papers authored by Mei Fen Shih

Since Specialization

Citations

This map shows the geographic impact of Mei Fen Shih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Fen Shih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Fen Shih more than expected).

Fields of papers citing papers by Mei Fen Shih

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei Fen Shih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Fen Shih. The network helps show where Mei Fen Shih may publish in the future.

Co-authorship network of co-authors of Mei Fen Shih

This figure shows the co-authorship network connecting the top 25 collaborators of Mei Fen Shih. A scholar is included among the top collaborators of Mei Fen Shih based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei Fen Shih. Mei Fen Shih is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Shih, Mei Fen, et al.. (2025). RRM1 O-GlcNAcylation inhibition suppresses pancreatic cancer via TK1-mediated replication stress. Cancer Gene Therapy. 32(5). 550–562.

Shih, Mei Fen, et al.. (2017). Treatment of β-thujaplicin counteracts di(2-ethylhexyl)phthalate (DEHP)-exposed vascular smooth muscle activation, inflammation and atherosclerosis progression. Regulatory Toxicology and Pharmacology. 92. 333–337. 19 indexed citations

Shih, Mei Fen & Jong Yuh Cherng. (2014). Reduction of Adhesion Molecule Production and Alteration of eNOS and Endothelin-1 mRNA Expression in Endothelium by Euphorbia hirta L. through Its Beneficial β-Amyrin Molecule. Molecules. 19(7). 10534–10545. 10 indexed citations

Cherng, Jong Yuh, Ting Hou, Mei Fen Shih, H. Talsma, & Wim E. Hennink. (2013). Polyurethane-based drug delivery systems. International Journal of Pharmaceutics. 450(1-2). 145–162. 218 indexed citations

Shih, Mei Fen, et al.. (2013). Chlorella 11-Peptide Inhibits the Production of Macrophage-Induced Adhesion Molecules and Reduces Endothelin-1 Expression and Endothelial Permeability. Marine Drugs. 11(10). 3861–3874. 45 indexed citations

Shih, Mei Fen, et al.. (2012). A one-step process in preparation of cationic nanoparticles with poly(lactide-co-glycolide)-containing polyethylenimine gives efficient gene delivery. European Journal of Pharmaceutical Sciences. 46(5). 522–529. 25 indexed citations

Shih, Mei Fen & Jong Yuh Cherng. (2012). Protective Effects of Chlorella-Derived Peptide Against UVC-Induced Cytotoxicity through Inhibition of Caspase-3 Activity and Reduction of the Expression of Phosphorylated FADD and Cleaved PARP-1 in Skin Fibroblasts. Molecules. 17(8). 9116–9128. 40 indexed citations

Cherng, Jong Yuh, Li‐Yin Chen, & Mei Fen Shih. (2012). Preventive Effects of β-Thujaplicin Against UVB-Induced MMP-1 and MMP-3 mRNA Expressions in Skin Fibroblasts. The American Journal of Chinese Medicine. 40(2). 387–398. 13 indexed citations

Shih, Mei Fen, et al.. (2011). Synthesis and Evaluation of Poly(hexamethylene-urethane) and PEG-Poly(hexamethylene-urethane) and Their Cholesteryl Oleyl Carbonate Composites for Human Blood Biocompatibility. Molecules. 16(10). 8181–8197. 11 indexed citations

10.

Shih, Mei Fen, et al.. (2008). The synthesis of cationic polyurethanes to study the effect of amines and structures on their DNA transfection potential. Journal of Controlled Release. 133(1). 68–76. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact